Gareth Kung - 18 Mar 2026 Form 3 Insider Report for Legend Biotech Corp (LEGN)

Role: Director
Signature: /s/ James Pepin, Attorney-in-Fact
Issuer symbol: LEGN
Transactions as of: 18 Mar 2026
Net transactions value: $0
Form type: 3
Filing time: 18 Mar 2026, 18:58:23 UTC
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Kung Gareth	Director	C/O LEGEND BIOTECH CORP, 2101 COTTONTAIL LANE, SOMERSET	/s/ James Pepin, Attorney-in-Fact	18 Mar 2026	0002121501

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	LEGN	Ordinary Shares						31,486	18 Mar 2026	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer.
F2	Includes 31,486 restricted share units (the "RSUs"). Each RSU represents a contingent right to receive one ordinary share of the Issuer upon settlement. 25% of the RSUs will vest on February 2, 2027 with the remainder vesting in 8 equal quarterly installments thereafter beginning on March 20, 2027, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Remarks:

Exhibit 24 - Power of Attorney